Early research on cancer drugs that use SHINE Technologies’ Illumira product found they could extend patients’ lifespans and more effectively treat kidney and prostate cancer, the Janesville company announced.
The business and WARF Therapeutics, the drug discovery program of the Wisconsin Alumni Research Foundation, recently released findings from research conducted at UW-Madison’s Advanced ...
Please log in to access subscriber content.
If you don't have a subscription, click
here for a WisPolitics free trial and to view the different subscription options.
